Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermidine synthase is an enzyme (EC 2.5.1.16; commonly abbreviated as SPDS) that catalyzes the transfer of a propylamine group from decarboxylated S-adenosylmethionine (dc-SAM) to putrescine, forming spermidine. This step is a critical part of polyamine metabolism, which is essential for cell proliferation, differentiation, and growth in both prokaryotic and eukaryotic organisms[7][5]. Most spermidine synthases function as homodimers and possess a two-domain structure with a conserved active site for the aminopropyltransferase activity[5][7]. In plants, SPDS plays additional roles in stress responses and development[4][5]. Inhibition or dysregulation of spermidine synthase has been linked to cancer, infectious diseases, and potentially other disorders where polyamine homeostasis is disrupted. Several inhibitors (notably cyclohexylamine and decarboxylated S-adenosylhomocysteine) target the active site and are tools for mechanistic or therapeutic studies[2][5][7].
Competitive inhibition of the active site (e.g., by cyclohexylamine); Inhibition via substrate or cofactor analogs (e.g., decarboxylated S-adenosylhomocysteine)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermidine synthase (SPDS).